Loading...

APC anti-mouse CD4 Antibody

Pricing & Availability
Clone
RM4-5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RM4-5_APC_030206
C57BL/6 mouse splenocytes stained with CD4 (clone RM4-5) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • RM4-5_APC_030206
    C57BL/6 mouse splenocytes stained with CD4 (clone RM4-5) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
See APC spectral data
Cat # Size Price Quantity Check Availability Save
100515 25 µg $33
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100516 100 µg $105
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes and a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a co-receptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
BALB/c mouse thymocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The RM4-5 antibody blocks the binding of GK1.5 antibody and H129.19 antibody to CD4+ T cells, but not RM4-4 antibody. Additional reported applications (for the relevant formats) include: blocking of ligand binding, in vivo depletion of CD4+ cells1, and immunohistochemistry of acetone-fixed frozen tissue sections2,3,11 and paraffin-embedded sections11. Clone RM4-5 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. Instead, acetone frozen or zinc-fixed paraffin sections are recommended. The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100575 and 100576).

Application References

(PubMed link indicates BioLegend citation)
  1. Kruisbeek AM. 1991. In Curr. Protocols Immunol. pp. 4.1.1-4.1.5. (Block, Deplete)
  2. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  3. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045.
  4. Muraille E, et al. 2003. Infect. Immun. 71:2704. (IHC)
  5. León-Ponte M, et al. 2007. Blood 109:3139. (FC)
  6. Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370. (FC)
  7. Matsumoto M, et al. 2007.J. Immunol.178:2499. PubMed
  8. Shigeta A, et al. 2008. Blood 112:4915. PubMed
  9. Zaborsky N, et al. 2010. J. Immunol. 184:725. PubMed
  10. Rodrigues-Manzanet R, et al. 2010. P. Natl Acad Sci USA 107:8706. PubMed
  11. Whiteland JL, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
Product Citations
  1. St Clair JR, et al. 2018. Nat Commun. 9:1742. PubMed
  2. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  3. Sheng W et al. 2018. Cell. 174(3):549-563 . PubMed
  4. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  5. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  6. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  7. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  8. Suzuki K, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:119. PubMed
  9. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  10. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  11. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  12. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  13. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  14. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  15. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  16. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  17. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  18. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  19. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  20. Denzin LK et al. 2017. Immunity. 47(2):310-322 . PubMed
  21. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  22. García–Rodríguez S, et al. 2018. Sci Rep. 2.664583333. PubMed
  23. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  24. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  25. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  26. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  27. Hartmann W, et al. 2020. Cell Reports. 29(8):2243-2256.e4.. PubMed
  28. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  29. Matsumoto M, et al. 2007. J Immunol . 178:2499. PubMed
  30. Shigeta A, et al. 2008. Blood. 112:4915. PubMed
  31. Rodriguez-Manzanet R, et al. 2010. Proc Natl Acad Sci U S A. 107:8706. PubMed
  32. Zaborsky N, et al. 2010. J Immunol. 184:725. PubMed
  33. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  34. Park S, et al. 2013. J Immunol. 190:3480. PubMed
  35. Palaniyandi S, et al. 2013. PLoS One. 8:61841. PubMed
  36. Tsumiyama K, et al. 2013. J Immunol. 191:91. PubMed
  37. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  38. Li C, et al. 2014. J Immunol. 192:1425. PubMed
  39. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  40. Nakajima A, et al. 2014. PLoS One. 9:105904. PubMed
  41. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  42. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  43. Berry G, Waldner H 2013. J Vis Exp. 75: 50389. PubMed
  44. Xiao u, et al. 2015. J Immunol. 195: 4218 - 4227. PubMed
  45. Zaiss M, et al. 2015. Immunity. 43: 998-1010. PubMed
  46. Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
  47. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  48. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  49. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  50. Biton J, et al. 2016. J Immunol. 197: 1708 - 1719. PubMed
  51. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  52. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  53. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  54. Soon MSF, et al. 2020. Nat Immunol. 1.984027778. PubMed
  55. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  56. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  57. Cosgrove J, et al. 2020. Nat Commun. 3.011805556. PubMed
  58. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  59. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  60. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  61. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  62. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  63. Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed
  64. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  65. Lee J, et al. 2020. Gut Microbes. 1:. PubMed
  66. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  67. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
  68. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  69. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  70. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  71. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  72. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  73. van der Lelie D, et al. 2021. Nat Commun. 12:3105. PubMed
  74. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  75. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  76. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  77. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  78. Izumi G, et al. 2021. Nat Commun. 12:5029. PubMed
  79. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  80. Liu J, et al. 2021. Front Immunol. 12:733808. PubMed
  81. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  82. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  83. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  84. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  85. Kang S, et al. 2021. Bio Protoc. 11:e4029. PubMed
  86. Yu Y, et al. 2022. iScience. 25:105004. PubMed
  87. Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed
  88. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  89. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  90. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  91. Sudo K, et al. 2021. Stem Cell Res. 56:102531. PubMed
  92. Lin YW, et al. 2022. Mol Med Rep. 26:. PubMed
  93. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  94. Schnell A, et al. 2021. Cell. 184:6281. PubMed
  95. Casado-García A, et al. 2022. Cancer Res. 82:1098. PubMed
  96. Liu H, et al. 2022. Cancer Immunol Res. 10:1028. PubMed
  97. Wang W, et al. 2022. Cell Rep. 41:111582. PubMed
  98. Zheng D, et al. 2023. Bioact Mater. 22:567. PubMed
  99. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  100. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  101. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  102. Issa N, et al. 2023. Leukemia. :. PubMed
  103. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  104. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  105. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
RRID
AB_312718 (BioLegend Cat. No. 100515)
AB_312719 (BioLegend Cat. No. 100516)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.
Go To Top Version: 3    Revision Date: 01/29/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account